Stomach Neoplasms
📧 Sign up to get email alerts when something new happens for Stomach Neoplasms.
Sign up freeTop drugs studied for this disease
-
EMA withdrawal · 2022-05-20EMA Withdrawn: Docetaxel Zentiva (previously Docetaxel Winthrop) (docetaxel) — Zentiva k.s.
The EMA has withdrawn Docetaxel Zentiva (docetaxel) from the market. The therapeutic areas formerly associated include head and neck neoplas…
-
CLINICAL_TRIALS trial_result · 2021-12-28Clinical Trial Update: A Phase 1/2 Study Evaluating AMG 337 in Asian Subjects [Phase 1, Phase 2]
Phase 1/2 clinical trial update for AMG 337 in Asian subjects with stomach neoplasms.
-
CLINICAL_TRIALS withdrawal · 2021-12-16Clinical Trial Update: Pembrolizumab (MK-3475) Plus Chemotherapy Versus Placebo Plus Chemotherapy in Participants Gastric or Gastroesophageal Junction (GEJ) Adenocarcinoma (MK-3475-859/KEYNOTE-859)-China Extension [Phase 3]
A Phase 3 trial (MK-3475-859/KEYNOTE-859) evaluating pembrolizumab plus chemotherapy versus placebo plus chemotherapy in gastric/GEJ adenoca…
-
EMA withdrawal · 2021-12-14EMA Withdrawn: Docetaxel Teva (docetaxel) — Teva B.V.
The EMA has withdrawn Docetaxel Teva, an injectable chemotherapy containing docetaxel, from the European market.
-
CLINICAL_TRIALS trial_result · 2021-10-06Clinical Trial Update: Low-dose Neuroleptanalgesia for Postoperative Delirium in Elderly Patients [Phase 4]
Phase 4 clinical trial update exploring low-dose neuroleptanalgesia for postoperative delirium in elderly patients; current status is unknow…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2021-09-13Clinical Trial Update: Assessment of Ramucirumab Plus Paclitaxel as Switch MANteInance Versus Continuation of First-line Chemotherapy in Patients With Advanced HER-2 Negative Gastric or Gastroesophageal Junction Cancers [Phase 3]
A Phase 3 trial evaluating ramucirumab plus paclitaxel as switch maintenance versus continuation of first-line chemotherapy in advanced HER-…
-
CLINICAL_TRIALS trial_result · 2021-07-06Clinical Trial Update: Intraperitoneal Paclitaxel With XELOX in Gastric Cancer With Peritoneal Metastasis [Phase 1, Phase 2]
A Phase 1/2 trial evaluating intraperitoneal paclitaxel with XELOX in gastric cancer with peritoneal metastasis; current status not disclose…
-
CLINICAL_TRIALS trial_result · 2021-06-08Clinical Trial Update: Study of Vismodegib in Advanced Gastric Adenocarcinoma Patients With SMO Overexpression [Phase 2]
Phase 2 trial update of vismodegib in advanced gastric adenocarcinoma with SMO overexpression completed.
-
CLINICAL_TRIALS trial_result · 2021-04-13Clinical Trial Update: FOLFIRINOX vs FLOT Chemotherapy for Resectable Gastric or Esophagogastric Junction Adenocarcinoma [Phase 2, Phase 3]
Clinical trial comparing FOLFIRINOX vs FLOT as neoadjuvant chemotherapy for resectable gastric or esophagogastric junction adenocarcinoma; c…
-
CLINICAL_TRIALS trial_result · 2021-03-26Clinical Trial Update: Trial of S-1 Maintenance Therapy in Metastatic Esophagogastric Cancer [Phase 2]
Phase 2 trial evaluating S-1 maintenance therapy in unresectable, locally advanced or metastatic gastric/GEJ adenocarcinoma has been complet…
-
CLINICAL_TRIALS trial_result · 2020-09-07Clinical Trial Update: Impact of the Type of Reconstruction Methods on Diabetes Following Laparoscopic Distal Gastrectomy in Patients With Gastric Cancer and Type 2 Diabetes [Phase 2]
Phase 2 trial evaluating how reconstruction method after laparoscopic distal gastrectomy affects diabetes status in patients with gastric ca…
-
CLINICAL_TRIALS trial_result · 2020-07-16Clinical Trial Update: A Clinical Trial of Two Adjuvant Chemotherapy Regimens for Postoperative Gastric Cancer [Phase 3]
Phase 3 clinical trial update comparing two adjuvant chemotherapy regimens for postoperative gastric cancer.
-
CLINICAL_TRIALS trial_result · 2020-02-05Clinical Trial Update: Study on Laparoscopic Spleen-Preserving No. 10 Lymph Node Dissection for Advanced Gastric Cancer [Phase 2]
Phase 2 clinical trial update on laparoscopic spleen-preserving No. 10 lymph node dissection for advanced gastric cancer.
-
CLINICAL_TRIALS trial_result · 2020-01-18Clinical Trial Update: Combination Chemotherapy in Treating Patients With Advanced Stomach, Gastroesophageal, or Esophageal Cancer [Phase 2]
Phase 2 trial update for combination chemotherapy in advanced stomach, gastroesophageal, or esophageal cancer. The study completed with post…
-
CLINICAL_TRIALS trial_result · 2019-10-22Clinical Trial Update: Regorafenib in Combination With Paclitaxel in Advanced Oesophagogastric Carcinoma [Phase 1, Phase 2]
A Phase 1/2 trial evaluating regorafenib in combination with paclitaxel for advanced esophagogastric carcinoma has completed.
-
CLINICAL_TRIALS trial_result · 2019-10-16Clinical Trial Update: A Randomized Phase II Trial of Neoadjuvant Chemotherapy Compared With Chemoradiotherapy in Gastric Adenocarcinoma [Phase 2]
A randomized Phase II trial comparing neoadjuvant chemotherapy to chemoradiotherapy in gastric adenocarcinoma has completed.
-
EMA withdrawal · 2019-10-15EMA Withdrawn: Taxespira (previously Docetaxel Hospira UK Limited ) (docetaxel trihydrate) — Hospira UK Limited
The EMA withdrew Taxespira (docetaxel trihydrate) from the market for multiple cancer indications including stomach, prostate, breast, head …
-
CLINICAL_TRIALS trial_result · 2019-03-26Clinical Trial Update: The Maintenance Treatment of Apatinib/Capecitabine Versus Observation in Advanced Gastric Cancer [Phase 3]
Phase 3 trial update investigating maintenance therapy with apatinib/capecitabine versus observation in advanced gastric cancer.
-
CLINICAL_TRIALS research · 2018-07-26Clinical Trial Update: Application of 3D Printing Technique in Radical Gastrectomy With Leonardo da Vinci Robot [NA]
A clinical trial update exploring the use of 3D printing to assist radical gastrectomy performed with a Leonardo da Vinci robotic system for…
-
CLINICAL_TRIALS trial_result · 2018-03-23Clinical Trial Update: A Study of Intraperitoneal Paclitaxel in Combination With SOX Compared With SOX Alone in Gastric Cancer With Malignant Ascites [Phase 3]
Phase 3 clinical trial comparing intraperitoneal paclitaxel plus SOX versus SOX alone in gastric cancer with malignant ascites; current stat…
-
CLINICAL_TRIALS withdrawal · 2018-03-12Clinical Trial Update: Density of Neurons in the Stomach and Prognosis of Gastric Adenocarcinoma [NA]
The clinical trial NCT01821196 evaluating neuronal density in the stomach and prognosis of gastric adenocarcinoma has been withdrawn.
-
CLINICAL_TRIALS trial_result · 2018-03-09Clinical Trial Update: Botulinum Toxin for Stomach Cancer Treatment [Phase 2]
Phase 2 clinical trial evaluating botulinum toxin for stomach cancer has completed.
-
CLINICAL_TRIALS trial_result · 2018-01-23Clinical Trial Update: ECX + Panitumumab vs. ECX Alone in Locally Advanced Gastric Cancer or Cancer of the Gastroesophageal Junction [Phase 2]
Phase 2 trial comparing ECX + panitumumab versus ECX alone in locally advanced gastric cancer or cancer of the gastroesophageal junction has…
-
CLINICAL_TRIALS trial_result · 2018-01-17Clinical Trial Update: Study of Nimotuzumab and Irinotecan as Second Line With Recurrent or Metastatic Gastric Adenocarcinoma [Phase 2]
Phase 2 trial investigating nimotuzumab plus irinotecan as second-line therapy for recurrent or metastatic gastric adenocarcinoma.
-
CLINICAL_TRIALS trial_result · 2017-12-04Clinical Trial Update: A Study of Ramucirumab Combination Therapy in Japanese Participants Who Have Advanced Stomach Cancer [Phase 1]
Phase 1 trial update of ramucirumab in combination therapy for advanced stomach cancer in Japanese participants; study completed with result…